Globus Medical (GMED) Other Non-Current Liabilities (2011 - 2026)
Globus Medical (GMED) posted Other Non-Current Liabilities of $20.6 million for Q1 2026, down 3.59% on a QoQ basis from $21.3 million in Q4 2025, and down 82.57% year-over-year from $118.1 million in Q1 2025.
Globus Medical (GMED) Other Non-Current Liabilities (2011 - 2026) Analysis & Trends
Globus Medical's Other Non-Current Liabilities history runs 16 years deep, the most recent figure standing at $20.6 million for Q1 2026.
- Quarterly Other Non-Current Liabilities fell 82.57% year-over-year to $20.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.6 million (down 82.57% YoY) and the FY2025 annual result came in at $21.3 million, down 0.87% from the prior year.
- Other Non-Current Liabilities was $20.6 million for Q1 2026 at Globus Medical, down from $21.3 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $118.1 million in Q1 2025 and bottomed at $10.3 million in Q4 2022.
- A 5-year average of $47.5 million and a median of $25.1 million in 2025 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2025 — Other Non-Current Liabilities jumped 316.47% — and 2026, when it sank 82.57%.
- Globus Medical's Other Non-Current Liabilities stood at $10.3 million in 2022, then jumped by 137.76% to $24.6 million in 2023, then slipped by 12.46% to $21.5 million in 2024, then declined by 0.87% to $21.3 million in 2025, then retreated by 3.59% to $20.6 million in 2026.
- Business Quant data shows GMED's Other Non-Current Liabilities at $20.6 million in Q1 2026, $21.3 million in Q4 2025, and $25.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Globus Medical | 10.21 Bn | 9.58 Bn | 525.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.58 Mn |
| Dec 31, 2025 | 21.34 Mn |
| Sep 30, 2025 | 25.08 Mn |
| Jun 30, 2025 | 104.97 Mn |
| Mar 31, 2025 | 118.06 Mn |
| Dec 31, 2024 | 21.53 Mn |
| Sep 30, 2024 | 22.98 Mn |
| Jun 30, 2024 | 25.21 Mn |
| Mar 31, 2024 | 111.31 Mn |
| Dec 31, 2023 | 24.60 Mn |
| Sep 30, 2023 | 22.40 Mn |
| Jun 30, 2023 | 65.35 Mn |
| Mar 31, 2023 | 64.88 Mn |
| Dec 31, 2022 | 10.35 Mn |
| Sep 30, 2022 | 12.60 Mn |
| Jun 30, 2022 | 68.31 Mn |
| Mar 31, 2022 | 68.04 Mn |
| Dec 31, 2021 | 12.64 Mn |
| Sep 30, 2021 | 15.88 Mn |
| Jun 30, 2021 | 48.00 Mn |